Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Lipisense by Lipigon Pharmaceuticals for Cardiometabolic Disease: Likelihood of Approval
Lipisense is under clinical development by Lipigon Pharmaceuticals and currently in Phase I for Cardiometabolic Disease. According to GlobalData, Phase...